MedTrace Logo

Post Marketing Observational Study of Retreatment of Chronic Hepatitis C With Peginterferon Alpha and Ribavirin (Study P06011)

NCT01098097 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 963

Last updated 2014-11-26

Study results available
· View outcomes & findings →

Summary

To study retreatment in patients who failed prior treatment with interferon alpha (pegylated or non-pegylated) with or without ribavirin in a real-life setting in an observational/noninterventional study.

Conditions

  • Hepatitis C, Chronic

Interventions

BIOLOGICAL

Peginterferon alpha

Peginterferon alpha given in combination with ribavirin according to local labeling guidelines

DRUG

Ribavirin

Ribavirin given in combination with peginterferon alpha according to local labeling guidelines

Sponsors & Collaborators

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-06-30
Primary Completion
2011-10-31
Completion
2011-10-31

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01098097 on ClinicalTrials.gov